News

Can AI and Biomarkers Make Mental Health Care More Measurable?

• By John K. Waters
• 06/23/2026

A new healthcare startup is betting that the future of mental health treatment will depend less on periodic symptom checklists and more on continuous streams of biological and behavioral data.

Attunio Health launched this week with a platform that combines artificial intelligence, laboratory testing, wearable device data, genetic insights, and remote monitoring to support what the company describes as a precision psychiatry approach.

The company's premise is that many aspects of mental health care remain difficult to measure objectively. Clinicians often rely on patient questionnaires, symptom descriptions, and follow-up appointments, which may be spaced weeks or months apart. Attunio argues that physiological signals collected between visits can provide additional context about factors affecting attention, executive function, emotional regulation, energy levels, and cognitive performance.

According to the company, the platform aggregates data from multiple sources, including wearable devices that track sleep, recovery, activity, stress, and heart rate variability; laboratory testing that measures metabolic, hormonal, inflammatory, and nutritional biomarkers; continuous glucose monitoring; pharmacogenomic information; symptom reporting; and medication response data.

The company said its proprietary intelligence platform analyzes these inputs to identify patterns, correlations, and potential warning signals that may not be apparent through conventional psychiatric evaluation alone.

Unlike traditional models that rely primarily on episodic appointments, Attunio said its platform continuously ingests physiological and behavioral data between visits. The company describes this as a closed-loop clinical intelligence system that provides ongoing feedback about patient progress.

Attunio emphasized that treatment decisions remain clinician-led. According to the company, licensed clinicians review patient information alongside AI-generated analyses and use that information to adjust treatment plans when appropriate.

"This creates a continuous feedback loop in which care plans can be refined based on objective changes in physiology, behavior, and treatment response," the company said in its announcement.

The platform is designed to help clinicians identify changes that may affect patient outcomes, including declining sleep quality, elevated physiological stress, glucose instability, biomarker changes associated with fatigue or mood regulation, and medication effectiveness or side-effect patterns.

The launch comes as several trends are reshaping healthcare technology. Consumer wearable adoption continues to expand, healthcare organizations are exploring AI-assisted clinical workflows, and researchers are increasingly studying the relationship between metabolic health and cognitive function.

At the same time, healthcare providers and regulators continue to examine how AI-generated recommendations should be validated, interpreted, and incorporated into clinical decision-making. While AI systems can help identify patterns in large datasets, questions remain about clinical effectiveness, transparency, and evidence-based outcomes across different patient populations.

Attunio's strategy places it at the intersection of several fast-growing sectors, including digital health, diagnostics, remote patient monitoring, precision medicine, and behavioral healthcare.

The company's longer-term vision extends beyond the treatment of mental health disorders. Attunio said it sees opportunities in cognitive performance, focus optimization, preventative brain health, and broader cognitive wellness applications.

Whether precision psychiatry becomes a mainstream healthcare model may depend on how effectively companies can demonstrate that continuous monitoring and AI-assisted analysis lead to better outcomes than traditional approaches. For now, Attunio is joining a growing group of healthcare technology companies attempting to make mental health care more measurable, personalized, and data-driven.

"Traditional psychiatry often lacks continuous objective feedback," an Attunio spokesperson said in the company's announcement. "Two patients may present with similar symptoms while having entirely different underlying drivers."

As AI, wearable technology, and biological monitoring become more common in healthcare, the question may be less about whether mental health care becomes more data-driven and more about how clinicians, patients, and healthcare systems choose to use that data.